These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 5319300

  • 1. [Clinical trial of a new neuroplegic drug, Dixyrazine, in a double blind experiment with subsequent serial analysis].
    Bensch K, Rundberg B.
    Psychiatr Neurol Med Psychol (Leipz); 1965 Mar; 17(3):96-100. PubMed ID: 5319300
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical study of a new neuroplegic drug, Dixyrazine, in a double-blind experiment with subsequent serial analysis].
    Bensch K, Rundberg B.
    Wien Z Nervenheilkd Grenzgeb; 1965 Mar; 22(3):217-24. PubMed ID: 4222763
    [No Abstract] [Full Text] [Related]

  • 3. [Some problems posed by double-blind investigation of psychotropic drugs: clinical trial of Nobrium Roche].
    Chistoni GC.
    Schweiz Arch Neurol Neurochir Psychiatr; 1971 Mar; 108(2):309-15. PubMed ID: 4941608
    [No Abstract] [Full Text] [Related]

  • 4. A methodological note on drug experimentation.
    Meile RL, Burk HW.
    Am J Ment Defic; 1971 May; 75(6):692-5. PubMed ID: 4932178
    [No Abstract] [Full Text] [Related]

  • 5. Propericiazin, diazepam, chlorpromazine and placebo in a doubleblind trial in pedopsychiatric therapy.
    Bartůnková Z, Cerný L, Drtilová J, Sturma J.
    Act Nerv Super (Praha); 1972 May; 14(2):83-4. PubMed ID: 4402693
    [No Abstract] [Full Text] [Related]

  • 6. Methodology for the clinical investigation of psychotherapeutic drugs.
    Hollister LE, Overall JE.
    J New Drugs; 1965 May; 5(5):286-93. PubMed ID: 5329632
    [No Abstract] [Full Text] [Related]

  • 7. The neuroleptics. 10. Therapeutic problems.
    Barahona-Fernandes HJ, Cazzullo CL, Cocchi A, Denber HC, Freyhan FA, Klerman GL, Köknel O, Levine J, Saarma J, Sarteschi P, Vinar O, Wittenborn JR.
    Mod Probl Pharmacopsychiatry; 1970 May; 5():148-56. PubMed ID: 4949818
    [No Abstract] [Full Text] [Related]

  • 8. The neuroleptics. 8. Clinical methodology.
    Ban TA, Bordeleau JM, Debray HR, Hamilton M, Ito H, Overall JE, Pichot P, Reda G, Tetreault L, Volmat R, Wiart C.
    Mod Probl Pharmacopsychiatry; 1970 May; 5():133-40. PubMed ID: 4949817
    [No Abstract] [Full Text] [Related]

  • 9. Polypharmacy in psychiatry: empiricism, efficacy, and rationale.
    Merlis S, Beyel V, Fiorentino D, Fracchia J, Sheppard C.
    Curr Psychiatr Ther; 1972 May; 12():89-97. PubMed ID: 4555860
    [No Abstract] [Full Text] [Related]

  • 10. Tybamate in the treatment of chronic mental patients.
    Fransway RL, Wells ML, Chen CH.
    Curr Ther Res Clin Exp; 1967 Jan; 9(1):42-5. PubMed ID: 4963023
    [No Abstract] [Full Text] [Related]

  • 11. [National and international legislative aspects of the neuropsychopharmacologic experimentation].
    Campailla G.
    Minerva Med; 1972 Nov 14; 63(81):4399-403. PubMed ID: 4565684
    [No Abstract] [Full Text] [Related]

  • 12. [Evaluation of the anti-anxiety activity of lorazepam in ambulatory patients].
    Terra SO, Bueno JR, Pires LL.
    J Bras Psiquiatr; 1971 Nov 14; 20(3):237-47. PubMed ID: 4950635
    [No Abstract] [Full Text] [Related]

  • 13. [Longitudinal profiles of the effects of psychotropic drugs from clinico-methodological viewpoint].
    Helmchen H, Müller-Oerlinghausen B.
    Arzneimittelforschung; 1974 Jul 14; 24(7):976-80. PubMed ID: 4603668
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical trials of a new anxiolytic, medazepam (Nobrium)].
    Boutillier H.
    Ann Med Psychol (Paris); 1970 Apr 14; 1(4):617-30. PubMed ID: 5450932
    [No Abstract] [Full Text] [Related]

  • 15. [CLINICAL TRIAL OF A NEW NEUROPLEGIC AGENT, DIXYRAZINE, WITH APPLICATION OF A DOUBLE-BLIND CONTROL METHOD AND SEQUENTIAL ANALYSIS].
    BENSCH K, RUNDBERG B.
    Acta Neurol Psychiatr Belg; 1964 Jul 14; 64():649-56. PubMed ID: 14212712
    [No Abstract] [Full Text] [Related]

  • 16. A clinical trial with mesoridazine (another phenodiazine derivative).
    Rudy L, Marozas RJ, Sykes D, Smith JA.
    Dis Nerv Syst; 1968 Jun 14; 29(6):412-3. PubMed ID: 4877749
    [No Abstract] [Full Text] [Related]

  • 17. The value of worsening rates in psychiatric clinical trials.
    Dull TA, Tuzel IH, White RF.
    Psychosomatics; 1970 Jun 14; 11(1):50-4. PubMed ID: 4908032
    [No Abstract] [Full Text] [Related]

  • 18. [Double-blind study of the eutrophic effect of buclizine on children].
    Bormans A.
    Brux Med; 1971 Apr 14; 51(4):291-3. PubMed ID: 4931281
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical trial of a new anxiolytic drug: SAS 538].
    Arioni Faccini BM, Losavio T.
    Minerva Med; 1971 Feb 21; 62(15):669-82. PubMed ID: 5549141
    [No Abstract] [Full Text] [Related]

  • 20. A controlled trial of propericiazine and chlorpromazine in "behaviour disorders".
    Rajotte P, Giard N, Tétreault L.
    Curr Ther Res Clin Exp; 1966 Apr 21; 8(4):166-74. PubMed ID: 4379671
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.